
Pipeline· May 22, 2026 · 13 min read
Compendia listing gaps for oncology access before label expansion
By Ran Chen#Oncology#Market Access#Medicare Part D
Trial design, endpoints, real-world evidence, safety updates, and how evidence translates into market access.


